44 2033180199
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Journal of Cancer & Metastasis Research

Sign up for email alert when new content gets added: Sign up

Insulin-like growth factor system alters the differentiation of placental mesenchymal stem cells into skeletal muscle

Joint Event on 24th International Conference on CANCER RESEARCH AND PHARMACOLOGY & International Congress on STRUCTURAL BIOCHEMISTRY, STEM CELLS AND MOLECULAR BIOLOGY

August 5-6, 2019 | Singapore

Doaa Aboalola

Western University, Canada

Posters & Accepted Abstracts: J Can Res Metastasis

Abstract :

Insulin-like growth factors are major components of the stem cell niche, as they regulate proliferation and differentiation of many tissues including skeletal muscle. Insulin-like growth factor binding protein-6 (IGFBP-6) is expressed in developing muscle cells and is the main regulator of IGF-II (fetal IGF). To date, no previous studies have been reported relating placental mesenchymal stem cells (PMSCs), muscle differentiation, and IGFBP-6

We hypothesized that IGFBP-6 regulates the maintenance of pluripotency of PMSCs and promotes their differentiation into muscle.

Objectives:

1) to investigate the capacity of PMSCs to differentiate into muscle; and 2) to evaluate the intracellular and extracellular actions of IGFBP-6 on PMSCs muscle differentiation.

Methods: Chorionic villi were collected from preterm placenta and stem cell identity was verified. Cells were then differentiated into muscle for 14 days and the impact of IGFBP-6 was investigated by adding IGFBP-6 or silencing it using siRNA.

Results: Isolated cells differentiated into muscle cells, forming multi-nucleated fibers expressing muscle markers with increased levels of IGFBP-6 and decreasing levels of pluripotency markers. Additionally, extracellular addition of IGFBP-6 significantly increased protein levels of muscle commitment maker Pax3/7, with an increase at the earlier time points for muscle markers that goes down by time. Interestingly, both SOX2 and OCT4 levels correlate with IGFBP-6. On the other hand, silencing IGFBP-6, significantly decreased both pluripotency and differentiation markers at the earlier time points. we identified the signal transduction mechanisms of IGFBP-6 on muscle differentiation by placental mesenchymal stem cells (PMSCs). We also showed that muscle differentiation required activation of both AKT and MAPK pathways. Interestingly, we demonstrated that IGFBP-6 could compensate for IGF-2 loss and help enhance the muscle differentiation process by triggering predominantly the MAPK pathway independent of activating either IGF-1R or the insulin receptor (IR). These findings indicate the complex interactions between IGFBP-6 and IGFs in PMSC differentiation into the skeletal muscle and that the IGF signaling axis, specifically involving IGFBP-6, is important in muscle differentiation.

Conclusion: IGFBP-6 regulates PMSC differentiation into muscle, with more prominent effects at the beginning of the differentiation process when PMSCs commit to muscle formation.

Biography :

E-mail: [email protected]

 
Google Scholar citation report
Citations : 8

Journal of Cancer & Metastasis Research received 8 citations as per Google Scholar report

Top